FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

FDA D.I.S.C.O. Burst Edition: FDA approval of Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2-positive solid tumors


Episode Artwork
1.0x
0% played 00:00 00:00
Apr 26 2024 3 mins   2
Other Episodes
Listen to a soundcast of the April 5, 2024, FDA approval of Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2-positive solid tumors.
Download episode Share
Copy URL



Listen on Podcast Addict
Subscribe on Podcast Addict